| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.5 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.22 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.24 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.24 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |